2394 studies found for:    Pulmonary Disease, Chronic Obstructive
Show Display Options
Rank Status Study
21 Completed Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid Population
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: Subjects with COPD;   Other: Subjects without COPD
22 Completed
Has Results
Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: NVA237 100 µg;   Drug: Placebo;   Drug: NVA237 200 µg
23 Active, not recruiting Oral Cyclosporine in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: Cyclosporine
24 Not yet recruiting Treatment in Patients Hospitalized With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
25 Recruiting Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease
Conditions: Lung Diseases, Obstructive;   Pulmonary Disease, Chronic Obstructive;   Bronchitis, Chronic
Intervention: Device: Yamax Digi-Walker CW-700
26 Completed
Has Results
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: 125/25 mcg once-daily GSK573719/GW642444;   Drug: 125mcg once-daily GSK573719;   Drug: Placebo once-daily
27 Completed
Has Results
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS™ 250/50mcg;   Other: Placebo
28 Completed A Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
29 Completed
Has Results
Safety/Tolerability Study With AZD1236 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: AZD1236;   Drug: Placebo
30 Recruiting Is COPD a Risk Factor for Cardiovascular Disease?
Condition: Chronic Obstructive Pulmonary Disease
Intervention:
31 Completed Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium Bromide/Formoterol Fumarate;   Drug: Formoterol Fumarate
32 Completed
Has Results
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol 300 μg;   Drug: Placebo
33 Active, not recruiting Metformin in Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Metformin;   Drug: Placebo
34 Completed
Has Results
A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)
Condition: Pulmonary Disease, Chronic Obstructive
Intervention: Drug: GW685698/GW642444
35 Active, not recruiting An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: JNJ 49095397;   Drug: Placebo
36 Completed
Has Results
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: ADVAIR DISKUS 250/50 mg BID;   Drug: SEREVENT 50 mcg BID
37 Completed PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions: Pulmonary Disease, Chronic Obstructive;   Pulmonary Emphysema;   Chronic Bronchitis
Interventions: Drug: PROCHYMAL™;   Drug: Placebo
38 Completed
Has Results
Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35)
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: aclidinium bromide
39 Completed
Has Results
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Formoterol;   Drug: Placebo
40 Completed
Has Results
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Olodaterol (BI 1744);   Drug: Formoterol;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years